Apitegromab is an investigational treatment aimed at improving motor function for people living with spinal muscular atrophy. Scholar Rock said it has also submitted and received validation for its ...
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today reported financial results ...
Weight loss “wonder drug” Wegovy will cost Irish users around €220 a month as it is not currently availably under either the ...
FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
Artificial Intelligence is revolutionizing pharmaceuticals, accelerating drug discovery, and optimizing clinical trials. Yet, ...
Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now ...
HTA as described by the HTA Regulation is the multidisciplinary scientific evidence-based process that allows to determine the relative effectiveness of new or existing health technologies. HTA is a ...
The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback